Avanos Medical (AVNS) Net Cash Flow (2013 - 2026)

Avanos Medical's Net Cash Flow history runs 14 years deep, the most recent figure standing at -$23.2 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 85.6% year-over-year to -$23.2 million; the TTM figure through Mar 2026 stood at -$33.6 million (down 250.67% YoY), while the FY2025 annual figure was -$22.9 million, down 195.02% from the prior year.
• Net Cash Flow came in at -$23.2 million for Q1 2026 at Avanos Medical, down from $18.7 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $26.9 million in Q3 2023 to a low of -$32.9 million in Q1 2023.
• A 5-year average of -$2.9 million and a median of -$9.6 million in 2025 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow surged 1787.5% in 2022 and plunged 404.35% in 2023, its largest moves.
• Avanos Medical's Net Cash Flow stood at $6.9 million in 2022, then slumped by 404.35% to -$21.0 million in 2023, then surged by 209.05% to $22.9 million in 2024, then declined by 18.34% to $18.7 million in 2025, then sank by 224.06% to -$23.2 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$23.2 million, $18.7 million, and -$19.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison